An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Multimodal model delivers personalized risk estimates and clinician-adjustable insights to support surgical decisions.

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...

Rectal cancer deaths among millennials under 45 are rising 2–3 times faster than colon cancer. Doctors urge early symptom ...

UB and Roswell Park researchers created MIRACLE, an AI tool that combines clinical data, CT imaging and LLM insights to ...

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and ...

GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...

Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

This review examines how high-throughput proteomics is expanding precision medicine by improving biomarker discovery, disease ...

At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

A new robotic procedure is transforming how doctors detect and treat lung cancer, helping catch it earlier and improve ...